CD8A and cancer: Since this has been verified using CTL generated in normal individuals [29] as well as in cancer patients [30], a reasonable conclusion is that the fine specificity of the residual repertoire in cancer patients does not differ from that of normal individuals, suggesting that peripheral tolerance does not result in a preferential expansion of CD8 T cells reactive with that tumor.